Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional dissection of the prototype foamy virus glycoprotein heparan sulfate binding site.

Retrovirology·2026
Same author

Thirteenth International Foamy Virus Conference-Meeting Report.

Viruses·2025
Same author

2024 taxonomy update for the family Retroviridae.

Archives of virology·2025
Same author

Timed chromatin invasion during mitosis governs prototype foamy virus integration site selection and infectivity.

Nucleic acids research·2025
Same author

Setting up an institutional OMERO environment for bioimage data: Perspectives from both facility staff and users.

Journal of microscopy·2024
Same author

Integrated cryoEM structure of a spumaretrovirus reveals cross-kingdom evolutionary relationships and the molecular basis for assembly and virus entry.

Cell·2024

Related Experiment Video

Updated: May 28, 2026

Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

Foamy virus biology and its application for vector development.

Dirk Lindemann1, Axel Rethwilm

  • 1Institut für Virologie, Medizinische Fakultät "Carl Gustav Carus", Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany. dirk.lindemann@tu-dresden.de

Viruses
|October 14, 2011
PubMed
Summary

Foamy viruses (FV) are unique retroviruses with a distinct replication strategy and apparent apathogenicity. Their properties make them promising candidates for gene therapy applications.

Keywords:
Fanconi AnemiaFoamyvirusesLADretroviral vectors

More Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Related Experiment Videos

Last Updated: May 28, 2026

Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Area of Science:

  • Virology
  • Molecular Biology
  • Gene Therapy

Background:

  • Foamy viruses (FV) are retroviruses found in various animal species.
  • They exhibit unique replication strategies, combining retroviral and hepadnaviral features.
  • FVs are generally apathogenic in natural hosts and humans.

Purpose of the Study:

  • To review current knowledge on foamy virus (FV) biology.
  • To explore the potential of FVs as gene transfer systems.
  • To highlight FV's unique characteristics compared to orthoretroviruses.

Main Methods:

  • Literature review of FV biology and gene therapy applications.
  • Comparative analysis of FV replication strategy and integration profile.
  • Assessment of FV vector properties for gene transfer.

Main Results:

  • FVs possess a unique replication cycle with late reverse transcription and distinct particle release.
  • Their integration profile differs from orthoretroviruses.
  • FV vectors show potential advantages over orthoretroviral vectors for gene therapy.

Conclusions:

  • Foamy viruses (FVs) represent a distinct class of retroviruses with unique biological properties.
  • Their inherent characteristics suggest significant potential as gene therapy vectors.
  • Further research into FV biology and vector development is warranted.